Transfection Reagents and Equipment Market, By Product (Reagents and Equipment), By Method (Biochemical Methods, Physical Methods, and Viral Methods), By End User (Pharmaceutical and Biotechnology Companies and Academics and Research Institutes), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Published In : Apr 2023

Code : CMI5659

Pages :162

Formats :

Excel and PDF

Industry : Biotechnology

Transfection Reagents And Equipment MarketSize and Trends

The global transfection reagents and equipment market was valued at US$ 1,066.5 Mn in 2022 and is forecast to reach a value of US$ 2,171.7 Mn by 2030 at a CAGR of 9.3% between 2023 and 2030. The global transfection reagents and equipment market is experiencing strong growth owing to the rise in burden of chronic diseases worldwide and rise in demand for transfection reagents and equipment. Moreover, increase in focus on the development of novel therapies and increase in research and development (R&D) across the globe is expected to boost the growth of the market. However, factors such as high cost of transfection reagents and selective effectiveness and certain limitations of transfection reagents are expected to hamper the market growth.

Global Transfection Reagents and Equipment Market Trends:

Need for early diagnosis is a recent trend

Over the years, the use of biopharmaceutical products has increased significantly for the treatment of many pathological conditions, such as cancer and genetic diseases, among others. With the rise in burden of such diseases, the need for early diagnosis and treatments is also increasing rapidly. Thus, players in the market have increased their investment and research for the development of such therapies (transfection reagent and equipment are highly required in such research processes). This trend is expected to continue during the forecast period.

Need for novel therapies/treatment is another trend

Pharmaceutical and biotechnology companies are on a continuous hunt for identifying new therapy and treatment for the diseases, as the burden of life-threatening diseases increases, synthetic genes and genomics have become an attractive area for investment, and is expected to offer tremendous opportunities for players in the market. Moreover, players in the market collaborating or signing partnership agreements to enhance their production and commercialization capabilities. This trend is also expected to continue over the forecast period.